Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Price Over Earnings Overview: Biogen
March 31, 2023
Tickers
BIIB
Tags
Market News
Benzinga
Markets
From
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
News
BIIB
From
Benzinga
Biogen Unusual Options Activity
March 23, 2023
Tickers
BIIB
Tags
BZI/UOA
BIIB
Options
From
Benzinga
11 Analysts Have This to Say About Biogen
March 23, 2023
Tickers
BIIB
Tags
Market News
Benzinga
BIIB
From
Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
Tickers
BIIB
BNTX
GIB
MRNA
Tags
QCOM
MRNA
Stocks to Buy
From
InvestorPlace
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
General
Benzinga
Market News
From
Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Tickers
BIIB
Tags
BIIB
General
Benzinga
From
Benzinga
Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?
March 22, 2023
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
Tickers
BIIB
ESALY
HRMY
INCY
Tags
INCY
Stocks to Buy
ESALY
From
InvestorPlace
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
BIIB
IONS
AMLX
From
MarketWatch
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Tickers
BIIB
Tags
FDA
Briefs
News
From
Benzinga
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Tickers
BIIB
NVS
SGMO
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Should You Buy Biogen Before a Big July Decision?
March 19, 2023
Tickers
BIIB
Tags
Recent Press Releases
ESAI/Y
BIIB
From
Motley Fool
Price Over Earnings Overview: Biogen
March 17, 2023
Tickers
BIIB
Tags
News
BIIB
BZI/PE
From
Benzinga
(BIIB) - Analyzing Biogen's Short Interest
March 17, 2023
Tickers
BIIB
Tags
Short Sellers
Benzinga
Market News
From
Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
Trading Ideas
Markets
Biotech
From
Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Benzinga
Market News
Regulations
From
Benzinga
Biogen's Debt Overview
March 15, 2023
Tickers
BIIB
Tags
Intraday Update
BIIB
News
From
Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Large Cap
Movers
ESALF
From
Benzinga
1 Reason to Buy Biogen Stock, and 1 Reason to Sell
March 14, 2023
Tickers
BIIB
Tags
Market News
Recent Press Releases
BIIB
From
Motley Fool
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
March 13, 2023
Tickers
BIIB
SAGE
Tags
General
Movers
Biotech
From
Benzinga
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
March 09, 2023
Tickers
BIIB
SAVA
Tags
BIIB
Market News
SAVA
From
InvestorPlace
Why Shares of Anavex Life Sciences Rose 12.4% in February
March 06, 2023
Tickers
AVXL
BIIB
Tags
BIIB
Recent Press Releases
ESAI/Y
From
Motley Fool
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
March 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
General
ESALF
Large Cap
From
Benzinga
Medicare just crushed the hopes of 750,000 Alzheimer’s patients a year
March 03, 2023
Tickers
BIIB
SPX
Tags
RUT
JP:4523
BIIB
From
MarketWatch
What Does Biogen's Debt Look Like?
March 02, 2023
Tickers
BIIB
Tags
Benzinga
Market News
Markets
From
Benzinga
Peering Into Biogen's Recent Short Interest
March 01, 2023
Tickers
BIIB
Tags
Trading Ideas
BZI/SHORTHIST
Short Ideas
From
Benzinga
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
XPH
RETA
BIIB
From
MarketWatch
Why Reata Pharmaceuticals Shares Are Falling Monday?
February 27, 2023
Tickers
BIIB
RETA
Tags
RETA
Market News
Benzinga
From
Benzinga
Analyst Initiates Coverage of GE Healthcare, Says' Path To Greatness Well-Paved'
February 17, 2023
Tickers
BIIB
GE
GEHC
Tags
Benzinga
Market News
Price Target
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today